EcoDrugPlus

Purinergic Receptor P2x 7

Ensembl ID : ENSOPRG00000014173
Gene Symbol: P2RX7
1 Cross references
187 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSOPRG00000008511
Gene Symbol: P2RY12
1 Cross references
180 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSOPRG00000014077
Gene Symbol: RAMP1
2 Cross references
253 Possible Orthologues:

Renin

Ensembl ID : ENSOPRG00000001334
Gene Symbol: REN
1 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSOPRG00000013157
Gene Symbol: RET
1 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSOPRG00000012948
Gene Symbol: RARB
1 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSOPRG00000005114
Gene Symbol: RARG
1 Cross references
449 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSOPRG00000000905
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSOPRG00000014490
Gene Symbol: RXRG
1 Cross references
273 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSOPRG00000007771
Gene Symbol: RPL10A
1 Cross references
204 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOPRG00000011078
Gene Symbol: RPL12
1 Cross references
219 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOPRG00000001194
Gene Symbol: RPL13A
1 Cross references
313 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).